Bulletin from Physitrack PLC’s (publ) Annual General Meeting - Seite 2

Share Repurchases

The AGM resolved, in accordance with the Board of Directors' proposal, that the Company be and is hereby generally and unconditionally authorised in accordance with section 701 of the Act to make market purchases (within the meaning of section 693 of the Act) of its Ordinary Shares, provided that:

a. the maximum number of Ordinary Shares authorised to be purchased shall be 1,626.077 (representing 10% of the Company's issued Ordinary Share capital at the date of this notice of Annual General Meeting);

b. the minimum price (exclusive of any expenses) which may be paid for an Ordinary Share is £0.001;

c. the maximum price (exclusive of expenses) which may be paid for each Ordinary Share must not be more than the higher of (i) an amount equal to five per cent above the market value of an Ordinary Share for the five business days immediately preceding the day on which that share is contracted to be purchased; and (ii) an amount equal to the higher of the price of the last independent trade and the highest current independent bid on the trading venue where the purchase is carried out, in each case exclusive of expenses;

d. the authority hereby conferred shall expire at the conclusion of the next Annual General Meeting of the Company to be held after the date of the passing of this resolution or, if earlier, on the expiry of 15 months from the passing of this resolution, unless such authority is renewed to such time; and

e. the Company may make a contract to purchase Ordinary Shares under the authority, which will or may be executed wholly or partly after the expiration of such authority and may make a purchase of Ordinary Shares pursuant to any such contract.

Please refer to the Notice of Annual General Meeting 2024 (link here) for full details of all the resolutions proposed at the Meeting.
https://www.physitrackgroup.com/press-release?slug=notice-of-annual-ge ...

Enquiries regarding this announcement should be addressed to:
Henrik Molin, CEO, Physitrack
[phone]
[e-mail]

About Physitrack
Physitrack PLC, founded in 2012, is a global digital healthcare provider, focused on the B2B wellness and virtual-first care markets. With staff on four continents, customers in 17 time zones, and end users in 187 countries, Physitrack is a truly global company.

The company has two business lines:

1. Lifecare Technology - SaaS platform tailored mainly to physiotherapy and musculoskeletal care, enabling practitioners to deliver clinical home exercises, education prescription, outcomes tracking, triaging and Telehealth.

2. Virtual-first Wellness / Champion Health - SaaS platform for Employee Wellness and care powered by a combination of world-leading technology and wellness professionals based in the United Kingdom, Germany and the Nordics.

Physitrack PLC is headquartered in London, United Kingdom, and listed on Nasdaq First North Premier Growth Market (PTRK).

Visit us at https://www.physitrackgroup.com/

Attachments

Bulletin from Physitrack PLC's (publ) Annual General Meeting

SOURCE: Physitrack

View the original press release on accesswire.com


The Physitrack Stock at the time of publication of the news with a fall of -0,67 % to 3,685EUR on Frankfurt stock exchange (06. April 2022, 14:01 Uhr).